Product Images Onzetra Xsail

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Onzetra Xsail NDC 42847-311 by Currax Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - onzetra 01

Chemical Structure - onzetra 01

Figure 1 - onzetra 02

Figure 1 - onzetra 02

Figure - onzetra 03

Figure - onzetra 03

This is a set of instructions on how to use Onzetra Xsail, a medication delivery device for the nose. The user needs to insert the nosepiece and pierce the medication capsule, then place the nosepiece in their nostril while rotating the device to place the mouthpiece in their mouth. They should blow into the device for a few seconds to deliver the medication into their nose. Then they should check the capsule to see if the medication is gone and discard the used nosepiece. The process should be repeated with the second nosepiece in the other nostril. If there is any residue after use, the user can repeat the steps with the same nosepiece, but if one or both capsules appear unused, they should contact their healthcare provider.*

PRINCIPAL DISPLAY PANEL - 11 mg Pouch Carton - onzetra 04

PRINCIPAL DISPLAY PANEL - 11 mg Pouch Carton - onzetra 04

ONZETRA Xsail is a prescription medication in the form of sumatriptan nasal powder, with each nosepiece containing 11 mg of the active drug. The medication is intended for intranasal use only and should be stored at room temperature, with no need for refrigeration. A typical dose is 22 mg delivered intranasally, with two reusable blue devices provided for immediate use and as a spare. The medication comes in a package with 16 nosepieces, equal to 8 doses, with two nosepieces per pouch. Before use, patients are advised to read the instructions carefully to ensure proper administration. The medication is distributed by Currax Pharmaceuticals LLC and contains trademarks registered in the United States and other countries.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.